AngioDynamicsANGO
About: AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Employees: 675
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
64% more call options, than puts
Call options by funds: $364K | Put options by funds: $222K
10% more capital invested
Capital invested by funds: $332M [Q1] → $365M (+$33.1M) [Q2]
3.32% more ownership
Funds ownership: 87.14% [Q1] → 90.45% (+3.32%) [Q2]
2% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 53
0% more funds holding in top 10
Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]
4% less funds holding
Funds holding: 154 [Q1] → 148 (-6) [Q2]
14% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 21
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Lake Street Frank Takkinen | 146%upside $24 | Buy Initiated | 16 Jul 2025 |
HC Wainwright & Co. Yi Chen | 64%upside $16 | Buy Reiterated | 16 Jul 2025 |
Canaccord Genuity William Plovanic | 74%upside $17 | Buy Maintained | 16 Jul 2025 |
Financial journalist opinion
Based on 4 articles about ANGO published over the past 30 days









